Jatrorrhizine hydrochloride inhibits the proliferation and neovascularization of C8161 metastatic melanoma cells

Anti-Cancer Drugs

Volumn 24, Issue 7, 2013, Pages 667-676

  Liu, Ruifang ^a   Cao, Zhifei ^a   Pan, Yanyan ^a   Zhang, Gaochuan ^a   Yang, Ping ^a   Guo, Pengda ^a   Zhou, Quansheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

angiogenesis; jatrorrhizine hydrochloride; medicinal herbs; melanoma; neovascularization; vasculogenic mimicry; VE cadherin

Indexed keywords

ANTIMETASTATIC AGENT; COPTIS CHINENSIS EXTRACT; JATRORRHIZINE HYDROCHLORIDE; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; COPTIS CHINENSIS; DOSE RESPONSE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTATIC MELANOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BERBERINE; CELL LINE, TUMOR; GROWTH INHIBITORS; HUMANS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84879990335     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328361ab28     Document Type: Article

References (36)

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
2. Eggermont AM, Robert C. Melanoma in 2011: a new paradigm tumor for drug development. Nat Rev Clin Oncol 2012; 9:74-76.
3. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science 2010; 328:240-243.
4. Feng Y, Zhang S, Tu J, Cao Z, Pan Y, Shang B, et al. Novel function of scutellarin in the inhibiting cell proliferation and inducing cell apoptosis of human Burkitt's lymphoma Namalwa cells. Leuk Lymphoma 2012; 53:2456-2464.
5. Bao M, Cao Z, Yu D, Fu S, Zhang G, Yang P, et al. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity. Toxicol Lett 2012; 215:174-180.
6. Cao Z, Yu D, Fu S, Zhang G, Pan Y, Bao M, et al. Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicol Lett 2013; 218:174-185.
7. He C, Rong R, Liu J, Wan J, Zhou K, Kang JX. Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells. Chin Med 2012; 7:11-16.
8. Chao J, Lu TC, Liao JW, Huang TH, Lee MS, Cheng HY, et al. Analgesic and anti-inflammatory activities of ethanol root extract of Mahonia oiwakensis in mice. J Ethnopharmacol 2009; 125:297-303.
9. Slobodnikova L, Kost'alova D, Labudova D, Kotulova D, Kettmann V. Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytother Res 2004; 18:674-676.
10. Patel MB, Mishra S. Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia. Phytomedicine 2011; 18:1045-1052.
11. Luo T, Zhang H, Zhang WW, Huang JT, Song EL, Chen SG, et al. Neuroprotective effect of jatrorrhizine on hydrogen peroxide-induced cell injury and its potential mechanisms in PC12 cells. Neurosci Lett 2011; 498:227-231.
12. Wang TX, Li K, Wang SG, Cong R, Wang YY. Study on jatrorrhizine inducing K562 cells apoptosis. Chin Pharm J 2010; 45:1882-1886.
13. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999; 155:739-752.
14. Van der Schaft DW, Seftor RE, Seftor EA, Hess AR, Gruman LM, Kirschmann DA, et al. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst 2004; 96:1473-1477.
15. Hess AR, Margaryan NV, Seftor EA, Hendrix MJ. Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn 2007; 236:3283-3296.
16. Marneros AG. Tumor angiogenesis in melanoma. Hematol Oncol Clin North Am 2009; 23:431-446.
17. Emmett MS, Dewing D, Pritchard-Jones RO. Angiogenesis and melanoma-from basic science to clinical trials. Am J Cancer Res 2011; 1:852-868.
18. Lai CY, Schwartz BE, Hsu MY. CD133 + melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res 2012; 72:5111-5118.
19. Liu R, Cao Z, Tu J, Pan Y, Shang B, Zhang G, et al. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment Cell Melanoma Res 2012; 25:630-638.
20. Zhou Q, Kiosses WB, Liu J, Schimmel P. Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine. Methods 2008; 44:190-195.
21. Zhou Q, Kapoor M, Guo M, Belani R, Xu X, Kiosses WB, et al. Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nat Struct Mol Biol 2010; 17:57-61.
22. Bu Z, Pan Y, Shang B, Cao Z, Zhou Q, Ruan C. SZ-117, a monoclonal antibody against matrix metalloproteinase-2 inhibits tumor cell-mediated angiogenesis. Hybridoma (Larchmt) 2012; 31:63-67.
23. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-674.
24. Shang B, Cao Z, Zhou Q. Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives. Front Med 2012; 6:67-78.
25. Sun B, Zhang S, Zhao X, Zhang W, Hao X. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 2004; 25:1609-1614.
26. Zhang S, Li M, Zhang D, Xu S, Wang X, Liu Z, et al. Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab Invest 2009; 89:575-586.
27. Zhou Q, Cao Z, Bao M, Shang B, Zhang G, Pan Y, et al. The molecular and cellular processes of tumor cell-mediated tumor angiogenesis and vasculogenesis. Blood 2011; 118:1405-1406.
28. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci USA 2001; 98:8018-8023.
29. Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, et al. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Cancer Res 2008; 68:1388-1397.
30. Dejana E, Giampietro C. Vascular endothelial-cadherin and vascular stability. Curr Opin Hematol 2012; 19:218-223.
31. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008; 121:2115-2122.
32. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008; 28:223-232.
33. Zhang LZ, Mei J, Qian ZK, Cai XS, Jiang Y, Huang WD. The role of VE-cadherin in osteosarcoma cells. Pathol Oncol Res 2010; 16:111-117.
34. Zhao X, Li Q, Bian L, Zheng X, Zheng J, Zhang Y, et al. Using immobilized G-protein coupled receptors to screen bioactive traditional Chinese medicine compounds with multiple targets. J Pharm Biomed Anal 2012; 70:549-552.
35. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Diz PG, Gandara RJM, Garcia-Garcia A. Beta-adrenergic receptors in cancer: therapeutic implications. Oncol Res 2010; 19:45-54.
36. Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res 2012; 18:1201-1206. Project